Investors

Presentations & Videos 2020

2020

For investor-related information please contact Ronn Bechler at Market Eye
Ph: +61 3 9591 8901 E: ronn.bechler@marketeye.com.au

Proactive – Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

Proactive – Zelira Therapeutics and Emyria team up for ‘disruptive’ autism spectrum disorder trial

Some excerpt

Investor Presentation – Non-Deal Roadshow
ASX Small and Mid-Cap Conference

Presentation – ASX Small and Mid-Cap Conference

Proactive – ASX Small and Mid-Cap Conference
Proactive – CEO Investor Sessions
Investor Presentation
Investor Presentation – Logistics for Benzinga conference
Investor Presentation – Non-deal Roadshow
Insomnia Phase 2 Clinical Trial Presentation
Investor Teleconference: Insomnia Trial Meets Primary and Secondary Endpoints
Proactive Interview – Zelira Therapeutics releases interim data for Phase II clinical trial for insomnia
Proactive Interview – Zelira Therapeutics releases interim data for Phase II clinical trial for insomnia

Start typing and press Enter to search

Shopping Cart